Rhode Island Hospital
Providence, Rhode Island, 02903, United States
NCT Number: NCT00603369
One subgroup of adolescents at particular risk for HIV is those with psychiatric disorders. Furthermore, those with histories of sexual abuse have been found to have riskier attitudes, poorer sexual communication skills, and less consistent condom use than non-abused peers. This study implemented and evaluated interventions for adolescents in intensive psychiatric treatment settings, particularly those with histories of sexual abuse. It is hypothesized that those participating in the intervention that addresses affect management and cognitive monitoring strategies will show fewer HIV-risk related behaviors and attitudes at posttest than peers in an information-based intervention.
Looking for future studies?
Notify Me13 year–19 year
All sexes
Interventional
Phase 1
Providence, Rhode Island, 02903, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
13-session intervention
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Rhode Island Hospital
Other
Acronym: Project STAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07750834
Acquired Immunodeficiency Syndrome, Behavior
Khartoum, Omdurman, Sudan
View Trial DetailsNCT05149001
Behavior, Blood-Borne Infections
Aix-en-Provence, France
View Trial DetailsNCT05732675
Behavior, Bisexuality
Ho Chi Minh City, Vietnam
View Trial DetailsNCT06012136
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Las Vegas, Nevada, United States
View Trial Details